Evidence map›Paper›PMID 32614283›Full record

ArticleEpidemiology and infection2020

The COVID-19 pandemic: a new challenge for syndromic surveillance.

Alex J Elliot, Sally E Harcourt, Helen E Hughes, Paul Loveridge, Roger A Morbey, Sue Smith, Ana Soriano, Amardeep Bains, Gillian E Smith, Obaghe Edeghere and 1 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Using routine emergency department data for syndromic surveillance of acute respiratory illness, Germany, week 10 2017 until week 10 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alex J ElliotReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.ORCID 0000-0002-6414-3065
Sally E HarcourtReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.ORCID 0000-0002-2278-9642
Helen E HughesReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.ORCID 0000-0002-3664-2983
Paul LoveridgeReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.
Roger A MorbeyReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.ORCID 0000-0001-8543-477X
Sue SmithReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.
Ana SorianoReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.
Amardeep BainsReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.
Gillian E SmithReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.ORCID 0000-0002-4257-0568
Obaghe EdeghereReal-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, UK.ORCID 0000-0002-4275-6338
Isabel OliverNational Infection Service, Public Health England, London, UK.ORCID 0000-0002-6106-1734

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic is exerting major pressures on society, health and social care services and science. Understanding the progression and current impact of the pandemic is fundamental to planning, management and mitigation of future impact on the population. Surveillance is the core function of any public health system, and a multi-component surveillance system for COVID-19 is essential to understand the burden across the different strata of any health system and the population. Many countries and public health bodies utilise 'syndromic surveillance' (using real-time, often non-specific symptom/preliminary diagnosis information collected during routine healthcare provision) to supplement public health surveillance programmes. The current COVID-19 pandemic has revealed a series of unprecedented challenges to syndromic surveillance including: the impact of media reporting during early stages of the pandemic; changes in healthcare-seeking behaviour resulting from government guidance on social distancing and accessing healthcare services; and changes in clinical coding and patient management systems. These have impacted on the presentation of syndromic outputs, with changes in denominators creating challenges for the interpretation of surveillance data. Monitoring changes in healthcare utilisation is key to interpreting COVID-19 surveillance data, which can then be used to better understand the impact of the pandemic on the population. Syndromic surveillance systems have had to adapt to encompass these changes, whilst also innovating by taking opportunities to work with data providers to establish new data feeds and develop new COVID-19 indicators. These developments are supporting the current public health response to COVID-19, and will also be instrumental in the continued and future fight against the disease.

Indexed as

Coronavirus InfectionsCOVID-19Health BehaviorHumansPandemicsPatient Acceptance of Health CarePneumonia, ViralPopulation SurveillancePublic Health SurveillanceChallengescoronavirusCOVID-19pandemicsurveillancesyndromic surveillance

Identifiers

PMID32614283
PMCPMC7338397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.